Collagen Solutions (COS)

 

COS Share PerformanceMore

52 week high10.250 19/07/16
52 week low4.600 20/12/16
52 week change -1.250 (-17.24%)
4 week volume3,135,913 27/12/16

Media for (COS)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

New Scientific Advisory Board appointments

RNS Number: 4776U Collagen Solutions PLC 19 January 2017 Collagen Solutions Plc (the "Company" or the "Group") Team Strengthened with New Scientific Advisory Board Appointments Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnos...

Collagen Solutions medical research studentship

Collagen Solutions has been awarded a third Medical Research Scotland Ph.D. studentship, this time in partnership with Pr...

Third Medical Research Scotland Ph.D. Studentship

Collagen Solutions Plc to present at the Growth and Innovation Forum 2017 in London on 31 January 2017

Jamal Rushdy, CEO of Collagen Solutions Plc (COS) [LSE:COS] the global supplier, developer, and manufacturer of medic...

Hardman Research: Foundations for strategic growth

Broker Forecast - Beaufort Securities issues a broker note on Collagen Solutions Plc

Beaufort Securities today downgrades its investment rating on Collagen Solutions Plc (LON:COS) to hold (from speculative...

Collagen's loss

Collagen Solutions posts a pre-tax loss of 983,313 for the six months to the end of September - up from 356,537 last time. Rev...

Collagen Solutions losses widen

Fundamental DataMore

EPS-0.57
Dividend yield0 %

Equity Research (COS)

hardman & co
Collagen Solutions PLC
21/12/2016
Interims – Foundations laid for strategic growth: Collagen Solutions is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, in vitro...
hardman & co
Collagen Solutions PLC
29/09/2016
Collagen Solutions is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, in vitro diagnostics, and regenerative medicine. The strategic...
Collagen Solutions PLC
15/09/2016
Collagen Solutions (COS.L) 1.13p £5.9m The developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, has been invited...

Latest discussion posts More

  • Panmure Gordon note - Research Tree

    Read Panmure Gordon & Co's note on COLLAGEN SOLUTIONS PLC (COS), out this morning, by visiting https://www.research-tree.com/company/GB00B94T6Y14 "Collagen Solutions has ...
    3-May-2016
    FoxRed
  • Panmure Gordon note - Research Tree

    Read Panmure Gordon & Co's note on COLLAGEN SOLUTIONS, out this morning, by visiting https://www.research-tree.com/company/GB00B94T6Y14 "Collagen Solutions announced yesterday ...
    27-Apr-2016
    FoxRed
  • Panmure Gordon note - Research Tree

    Read Panmure Gordon & Co's note on COLLAGEN SOLUTIONS, out this morning, by visiting https://www.research-tree.com/company/GB00B94T6Y14 "This morning Collagen Solutions has ...
    19-Apr-2016
    FoxRed

Users' HoldingsMore

Users who hold Collagen Solutions also hold..
LLOYDS GRP.31%
MONITISE25%
LEGAL&GEN.25%
PREMAITHA25%
SULA IRON25%

Codes & Symbols

ISINGB00B94T6Y14
SymbolsCOS, LSE:COS, COS.L, COS:LN, LON:COS, XLON:COS